Status:
RECRUITING
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Hiv
Alcohol Drinking
Eligibility:
All Genders
50+ years
Phase:
PHASE1
Brief Summary
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may int...
Detailed Description
Pilot 2 will consist of a brief pharmacist-led intervention for patients with HIV who consumed alcohol in the past month, take 5 or more medications in addition to their antiretroviral therapy (ART) r...
Eligibility Criteria
Inclusion
- HIV+
- have visited a local VA site in within the past year
- had an AUDIT-C indicating current alcohol use
- taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors)
Exclusion
- Inpatient individuals
- Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months
- Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process
Key Trial Info
Start Date :
January 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06513819
Start Date
January 15 2025
End Date
December 1 2025
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516